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Many human diseases, including Fanconi anemia, hemophilia B, neurofibromatosis, and phenylketonuria, can be
caused by 5-splice-site (5ss) mutations that are not predicted to disrupt splicing, according to position weight
matrices. By using comparative genomics, we identify pairwise dependencies between 5ss nucleotides as a conserved
feature of the entire set of 5ss. These dependencies are also conserved in human–mouse pairs of orthologous 5ss.
Many disease-associated 5ss mutations disrupt these dependencies, as can some human SNPs that appear to alter
splicing. The consistency of the evidence signifies the relevance of this approach and suggests that 5ss SNPs play a
role in complex diseases.
[Supplemental material is available online at www.genome.org.]
The sequenced genomes of a wide range of organisms allow glo-
bal, comparative analyses of regulatory sequences. The genomic
set of splice-site sequences corresponds to a large-scale splicing
experiment performed by nature under evolutionary constraints.
Here we focus on 5-splice-site (5ss) sequences of the U2-type
GT-AG class, which comprise over 98% of all splice sites, and use
disease-causing mutations, human single nucleotide polymor-
phisms (SNPs), and variations in natural splice sites in the ge-
nome (within and between species) to infer properties inherent
to 5ss, with important implications for human genetics.
Splice sites are conserved sequences at both ends of an in-
tron that are recognized during the initial steps of splicing (Hast-
ings and Krainer 2001; Brow 2002; Jurica and Moore 2003). Both
the 5ss and the 3 splice site (3ss) conform to degenerate motifs
that are recognized by specific splicing factors. The U2-type GT-
AG 5ss, spanning 3 nucleotides (nt) at the 3 end of the exon and
6 nt at the 5 end of the intron, is initially recognized via base
pairing to the 5 end of the U1 snRNA (Fig. 1; Zhuang and Weiner
1986; Séraphin et al. 1988; Siliciano and Guthrie 1988). Later in
the reaction, U5 and U6 snRNAs base pair to exonic or intronic
5ss positions, respectively (Newman and Norman 1992; Wassar-
man and Steitz 1992; Kandels-Lewis and Séraphin 1993; Lesser
and Guthrie 1993; Crotti et al. 2007). Additional elements influ-
ence splice-site selection, such as exonic or intronic splicing en-
hancers (ESE, ISE) or silencers (ESS, ISS) (Cartegni et al. 2002;
Ladd and Cooper 2002).
Even though the mammalian 5ss consensus sequence
(CAG|GTAAGT) is perfectly complementary to the 5 end of U1
snRNA, individual 5ss exhibit considerable variation at different
positions, indicating a tolerance for mismatches in U1 base pair-
ing. The free energy of the 5ss/U1 base pairing is not always a
good predictor of 5ss efficiency (Roca et al. 2005), suggesting the
existence of other factors that influence 5ss selection. It is
known that proteins such as the U1-C polypeptide (Du and Ros-
bash 2002), which is a component of the U1 snRNP, PRPF8 (also
known as PRP8) (Maroney et al. 2000), and members of the SR
and hnRNP protein families (Mayeda and Krainer 1992; Cáceres
et al. 1994; Buratti et al. 2004) are also involved in 5ss selection.
Most methods for estimating 5ss efficiency are based on position
weight matrices (PWMs) that are calculated from collections of
splice sites (for a depiction of a PWM, see Methods and Fig. 1)
(Shapiro and Senapathy 1987; Senapathy et al. 1990). Compared
with PWMs, which assume independence between positions
within the 5ss, methods that have considered the dependencies
between these positions (Brunak et al. 1991; Yeo and Burge 2004)
have provided some improvements in predicting 5ss efficiency
(Roca et al. 2003, 2005; Buratti et al. 2007). Such analyses have
been previously carried out on smaller data sets (Burge and Karlin
1997; Carmel et al. 2004) or implicitly considered in various 5ss
scoring algorithms (Brunak et al. 1991; Yeo and Burge 2004;
Krawczak et al. 2007).
Mutations at 5ss are frequent among mutations that cause
human disease, from genetic disorders to cancer (Krawczak et al.
1992; Nakai and Sakamoto 1994; Teraoka et al. 1999; Stenson et
al. 2003; Buratti et al. 2007). In many cases, the mutations cause
aberrant splicing by affecting the invariant GT dinucleotide at
positions +1 and +2 of the 5ss. However, the effects of other
disease-causing 5ss mutations are less clear-cut: Nucleotide sub-
stitutions affecting the less conserved positions can cause splic-
ing defects in some but not all 5ss, suggesting that the remaining
5ss positions and/or the overall context dictate the extent to
which splicing is disrupted.
We present a comprehensive analysis of the pairwise asso-
ciations between nucleotides at different 5ss positions, using the
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splice-site compilation from SpliceRack (Sheth et al. 2006), which
is a collection of more than 500,000 splice sites from five ge-
nomes. We explicitly and exhaustively identify combinations
that appear to be significant. We show that there are constraints
on combinations of nucleotides at different positions of the 5ss.
We further show that these constraints are indeed operational in
the evolutionary process using four data sets: disease-causing mu-
tations at 5ss, orthologous pairs of 5ss between mouse and hu-
man, SNPs at 5ss, and simulated SNPs. It is remarkable that all
these disparate sources of information seem to be consistent with
a single explanation: that the pairwise associations between po-
sitions of the 5ss are a determinant of 5ss efficiency.
Results
The primary determinant of the efficiency of a 5ss is its match to
the PWM (Zhuang and Weiner 1986; Séraphin et al. 1988; Sili-
ciano and Guthrie 1988) given by the log-odds score (Methods),
which reflects, at least in part, the stability of base pairing to the
U1 snRNA 5 end (Fig. 1). However, many 5ss with similar PWM
scores show differences in splicing efficiency, suggesting second-
ary effects that are ignored by the PWM. To study additional
determinants of 5ss efficiency, we have analyzed the associa-
tions between pairs of nucleotides at different positions of the
U2-type GT-AG 5ss in five species: Homo sapiens, Mus musculus,
Drosophila melanogaster, Caenorhabditis elegans, and Arabidopsis
thaliana.
Two-nucleotide associations
PWMs for each of the five species can be calculated from the
genomic 5ss data in SpliceRack (Sheth et al. 2006), consisting of
183,678 H. sapiens 5ss, 174,671 M. musculus 5ss, 40,367 D. me-
lanogaster 5ss, 93,699 C. elegans 5ss, and 111,351 A. thaliana
5ss. The PWMs are calculated by counting the occurrences of
nucleotides at each position within the 5ss. The expected occur-
rence of pairs of nucleotides at two positions, e.g., A at +4 and G
at +5, can be calculated from the PWM frequencies by assuming
independence between the two positions (for nomenclature of
positions in 5ss, see Fig. 1). The actual frequency of occurrence
for such pairs can be measured from the genomic data, by count-
ing the occurrence of pairs of nucleotides (16 possible combina-
tions) at all possible combinations of positions (21 unique com-
binations, if the +1 and +2 invariant positions are excluded). The
deviations of the actual count from the expected count are mea-
sured using a log-odds scoring scheme (see Methods), and for
visualization, the results are scaled and shown on a colored ma-
trix. A combined matrix showing data from M. musculus and H.
sapiens is depicted in Figure 2; a matrix for C. elegans and A.
thaliana is shown in Supplemental Figure S1; and the D. melano-
gaster matrix is shown in Supplemental Figure S2.
The surprising observation is that the pattern of deviations
of the actual counts from the expected counts is, to a great ex-
tent, conserved between species. This suggests that these patterns
of deviation are a result of the mechanisms of 5ss recognition by
the splicing machinery (e.g., cf. upper and lower triangles in Fig.
2 as well as Supplemental Figs. S1, S2). The mouse and human
patterns show remarkably close similarity. We show the variabil-
ity for a few pairs within the human genome and across genomes
in Table 1. There are some differences, but the overall patterns of
deviation are clearly preserved and presumably reflect the pres-
sures that arise from the conservation of the splicing machinery.
The depletion (maroon coloration) in the parts of the matrix
that connect the exonic and intronic portions of the 5ss is a
striking feature in all species (Figs. 2, S1, S2; see associations be-
tween positions 2 or 1 and positions +3, +4, +5, or +6). This
implies that having a nonconsensus nucleotide on the exonic
side causes a depletion of nonconsensus nucleotides on the in-
tronic side, and vice versa, which is consistent with the proposal
of a seesaw linkage pattern (Burge and Karlin 1997; Carmel et al.
2004). Some combinations are surprising in the distance they
span, such as the enhancement of the pair 1T+6T. The pair
1C+3C shows a strong depletion in all species, for reasons un-
known to us. Another striking pattern is the association between
positions 1 and +5 wherein a G (consensus) at 1 allows any
nucleotide at position +5; similarly, +5G (consensus) allows any
nucleotide at 1. We show some of the conserved pairwise as-
sociations in Table 1.
Some features in the pairwise association matrix might be
the result of constraints other than the splicing mechanism. For
example, the combinations 3T2A and 2T1A are severely
depleted in the five species, probably because these combinations
can be part of two of the three stop codons (TAG and TAA). The
combination +5C+6C is enriched, probably reflecting the gradual
conversion of U12-type GT-AG introns into U2-type GT-AG in-
trons (Burge et al. 1998; Sheth et al. 2006). From the pairwise
association matrix, it can be seen that the CpG dinucleotide is
depleted in higher species, whereas D. melanogaster and C. elegans
do not show such depletion, consistent with the fact that in
higher organisms CpG is underrepresented, due to methylation
of the C followed by de-amination (Tweedie et al. 1997). The
spliceosome could have evolved to use patterns that might be
species-specific, even though the drive to maintain the patterns
might come from other processes.
Figure 1. Features of the 5 splice site (5ss). (A) Base pairing between
the 5 end of the U1 snRNA and the consensus 5ss sequence.  denotes
pseudo-uridine, which is a modified uridine nucleotide capable of base
pairing to both A and G nucleotides. The conventional numbering of
positions relative to the exon–intron boundary is indicated. For example,
in the text 1G refers to nucleotide G at position 1. (B) A pictorial
representation of the position weight matrix (PWM) of the human U2-
type GT-AG 5ss; the bars represent the percentages of nucleotides at
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Another possible explanation for some of the pairwise asso-
ciations could lie in nucleotide biases in error-prone DNA repair.
However, the dependence of these mechanisms on the neighbor-
ing nucleotides is not very pronounced (Krawczak et al. 1998),
arguing against a large contribution to the associations.
There are some species-specific features in the pairwise as-
sociations. For example, there are tighter associations (brighter
blues) between the exonic nucleotides at positions 2 and 1 in
mammals and A. thaliana than in the two invertebrates (Figs. 2,
S1, S2). In contrast, D. melanogaster and C. elegans have more
biases between intronic nucleotides (positions +3 to +6 show
brighter blues).
The human genome is organized into isochores, i.e., regions
with relatively stable GC content compared with the variation of
the GC content across the genome (Costantini et al. 2006). The
isochores have been classified into five groups (H3 [GC > 53.5%],
H2 [46.6–53.5%], H1 [41.6–46.5%], L2 [37.6–41.5%], and L1
[<37.5%]). In order to use this stratification to study variations in
the associations, the 5ss were classified into the five isochore
categories, and the expected and actual counts for pairs within
each set were calculated. In Table 1 we show the variation of the
ratios of actual to expected counts for a selection of pairs. Overall,
the associations are preserved, both within and across species.
Implications for the splicing machinery
A striking feature that is conserved across species is the depletion
of U1-noncomplementary pairs across the exon–intron bound-
Figure 2. Association matrix for H. sapiens (upper right triangle, above diagonal) and M. musculus (lower left triangle, below diagonal). Row and column
labels identify each square; e.g., the square identified by row 3A and column +5T represents the pair 3A+5T in human, as it lies in the upper right
triangle. The color of the squares indicates the bias for (blue) or against (maroon) the pair of nucleotides. The log-odds score for each pair (the log of
the ratio of actual versus expected counts) is calculated and scaled so that the maximum positive value is assigned a score of +1 and the minimum
negative value is assigned a score of 1. The scale on the right shows the values indicated by the color tone. The diagonal elements are colored white,
and gray is used for associations within a position. Gray borders are used to mark the rows and columns containing consensus nucleotides at any given
position (e.g., +5G). A black square is used for the invariant (GT) dinucleotide at +1 and +2, and white lines are used to demarcate each position at the
5ss. Note that the association matrices for M. musculus and H. sapiens are strikingly similar.
Determinants of 5ss efficiency
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ary (e.g., 1C and +5T in Fig. 2). This implies that U1 snRNA
requires complementarity on at least one side of the invari-
ant GT.
After U1 snRNA is displaced from the 5ss, U5 snRNA binds
to the exonic 5ss positions via a U-rich sequence in the invariant
loop 1 (Newman and Norman 1992). However, we found that
combinations of A nucleotides at exonic positions are not en-
hanced, consistent with the finding that the U5 loop 1 is dis-
pensable in vivo in yeast (O’Keefe et al. 1996).
We observed that the pair +3C+4T is enhanced in the five
species. This association likely reflects base pairing to the U6
ACAGAG box (the nucleotides involved in base pairing to posi-
tions +3 and +4 are in italics) (Wassarman and Steitz 1992; Kan-
dels-Lewis and Séraphin 1993; Lesser and Guthrie 1993). The
remaining nucleotides that would base pair to U6 but not to U1
do not show an association that is phylogenetically conserved.
There are a number of biased combinations that cannot be
explained by base pairing to any of these snRNAs, such as an
enhancement of +4C+5C in all species, or 2C1T in the ver-
tebrates. Most importantly, these tend to be less conserved than
the previous associations. It is possible that these combinations
are part of binding sites for proteins that influence 5ss selection,
such as U1-C, PRPF8, SR proteins, or hnRNP proteins (Mayeda
and Krainer 1992; Cáceres et al. 1994; Maroney et al. 2000; Du
and Rosbash 2002; Buratti et al. 2004). Whether these dinucleo-
tide associations reflect a portion of a protein binding site and
whether the binding specificity of some of these proteins is
slightly different between species remain to be elucidated.
Scoring the pairwise associations within 5ss
We used the pairwise association matrix and a log-odds scoring
scheme to score 5ss for the level of association (see Methods).
This allowed us to quantify the effect of 5ss changes on splicing
efficiency. We used the data sets from disease-causing mutations,
SNPs at 5ss, orthologous mouse–human 5ss pairs, and simu-
lated SNPs at 5ss to estimate the magnitude of change in asso-
ciations that can significantly alter splice-site efficiency, and
then to predict SNPs at 5ss that can affect splicing (see below).
On the Web site accompanying this article (the URL is listed at
the end of the article), we present an interactive picture that
allows exploration of this pairwise-association matrix, which can
be used to study novel SNPs and mutations at 5ss for their pre-
dicted effects on splicing.
In Table 1 we show the variations for a few pairs across
isochores within the human genome. This establishes that, over-
all, the compositional variations can change the ratios, but the
trend remains the same; depleted (enhanced) pairs are depleted
(enhanced) in all sets, irrespective of the origin of the 5ss. Most
patterns are maintained across species, with the CpG motifs be-
ing prominent exceptions. The justification for the scoring
scheme lies in the conserved nature of these depletions and en-
hancements and in the fact that the scoring scheme is an indi-
cator of the effects of disrupting the pairwise association pat-
terns.
Disease-causing mutations at 5ss
We expected disease-causing mutations at 5ss to be disruptive of
the PWM scores as well as the pairwise-association scores. For this
study, we used 595 disease-causing 5ss mutations from the
HGMD database (Stenson et al. 2003) plus another independent
set (Madsen et al. 2006), excluding mutations that affect the
nearly invariant +1 and +2 positions.
The reduction in PWM scores caused by many of the muta-
tions cannot, by itself, explain the severe effects on splicing, be-
cause there are other pairs of functional 5ss in the human
genome that have the same nucleotide change. Indeed, we ob-
served that the natural 5ss tend to have better pairwise-
association scores than the mutant 5ss (Fig. 3).
We picked a well-studied set among disease-causing 5ss mu-
tations, i.e., a subclass that consists of A-to-G transitions at po-
sition +3, for further theoretical and experimental analyses. A
(59%) and G (35%) are both conserved at position +3 (Sheth et al.
2006), probably because both can base pair to a pseudo-uridine
nucleotide (), a post-transcriptionally modified uridine isomer
Table 1. A selection of pairwise associations in 5ss and their variations within and across genomes
Pair Actual/expected (H) Ratio (C.I.) (H) Ratio (isochores) Ratio (C,D,A,M)
3C2G 3637/7758 0.47 (0.46–0.48) 0.341–0.578 0.714,0.813,0.700,0.437
2C1G 9744/15,998 0.61 (0.60–0.62) 0.403–0.779 0.935,0.921,0.743,0.592
2T1A 1095/2598 0.42 (0.405–0.443) 0.334–0.448 0.434,0.376,0.419,0.401
1C+3C 12/129 0.09 (0.051–0.135) 0.002–0.020 0.569,0.139,0.099,0.082
1C+5T 9/371 0.024 (0.01–0.04) 0.000–0.008 0.391,0.234,0.266,0.038
1G+5A 15,887/13,233 1.20 (1.196–1.202) 1.158–1.265 1.375,1.285,1.166,1.194
+3T+4T 1484/538 2.758 (2.684–2.872) 1.544–3.265 2.099,2.440,1.447,2.499
+3T+5T 129/352 0.366 (0.326–0.429) 0.012–0.134 0.876,0.309,0.894,0.276
+3C+4T 816/556 1.467 (1.407–1.561) 1.036–2.844 0.384,1,1.436,1.679
+3C+5T 111/371 0.299 (0.267–0.364) 0.005–0.255 0.327,0.120,0.819,0.261
+3C+5A 74/445 0.166 (0.153–0.219) 0.041–0.204 0.159,0.162,0.635,0.181
+3A+5G 75,891/86,526 0.877 (0.875–0.878) 0.858–0.933 0.896,0.932,0.883,0.892
+3G+5A 1856/5753 0.322 (0.311–0.333) 0.273–0.385 0.605,0.379,0.676,0.319
+4C+5C 2431/705 3.448 (3.275–3.460) 1.443–2.246 0.666,0.354,1.094,3.326
+5C+6G 1206/1948 0.619 (0.595–0.649) 0.485–0.883 0.940,1.117,0.679,0.616
The confidence interval (C.I.) was established by using bootstrapping. The second and third columns show data for human splice sites, and the ratios
refer to actual count/expected count. We also used the five types of isochores in the human genome (H) (Costantini et al. 2006) to establish the variation
in the ratio of actual to expected counts (since random sampling may hide the stratification in the data). The isochores have an effect on adjacent pairs
that are CpG and on pairs that do not occur often, but the bias is always in the direction seen with the full genomic data set, confirming that the
depletion or elevation of pairs is under some selection pressure. The isochore numbers and the numbers for the species (C. elegans [C], D. melanogaster
[D], A. thaliana [A], M. musculus [M]) other than H. sapiens (H) correspond to the full data set, and the confidence intervals were not determined. Not
all splice sites map to isochores, and in addition, only sites that map uniquely were used in this calculation. They are shown to indicate the variability
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(Reddy et al. 1981) in the 5 arm of the U1 snRNA (Fig. 1). Thus,
it is not obvious why the A to G mutations at +3 in genes such as
ACADSB (also named SBCAD), BRCA1, APC, and NF1 can cause
genetic diseases (Madsen et al. 2006). It has been shown that 5ss
with disease-causing +3 A-to-G mutations exhibit two distinct
features: (1) They are intrinsically weak (Madsen et al. 2006); and
(2) they frequently have nonconsensus nucleotides at positions
+4 and +5 (for confirmation, see Fig. 4; Ohno et al. 1999; Madsen
et al. 2006). Figure 4 also shows that 5ss with G at position +3
and SNPs with A/G alleles at position +3 prefer consensus nucleo-
tides at +4 and +5, in agreement with the second observation.
These observations can be explained by the dependencies
between position +3 (A/G) and the nucleotides at positions +4
and +5 (Fig. 2). The association of +3A to nonconsensus nucleo-
tides at +4 (C, G, T) and +5 (A, C, T) is blue (enhanced), whereas
the association of +3G to nonconsensus nucleotides at +4 and +5
is maroon (depleted). An interesting prediction is that if both +4
and +5 are nonconsensus, then the splicing defect in the mutant
can be fixed by converting either +4 or +5 independently to the
consensus (see below).
Experimental tests of the associations
We carried out in vitro splicing experiments in order to confirm
our prediction for the +3 A-to-G mutations. We used a 5ss-
competition assay described in Figure 5. We inserted variants of
the 5ss (GGG/GUACAU) from exon 3 of the ACADSB gene into
a beta-globin (HBB) minigene, which allows direct comparison of
the efficiencies of any two 5ss (Roca et al. 2005). An A-to-G
mutation at position +3 of this 5ss causes a rare metabolic dis-
ease, ACADSB deficiency (Madsen et al. 2006).
First, we found that the +3 A-to-G mutation in the ACADSB
5ss severely reduces the 5ss strength (Fig. 6). When the ACADSB
wild-type 5ss (+3A) or its +3 A-to-G mutant version (+3G) were
tested in competition against the beta-globin cryptic 5ss at 16
(Treisman et al. 1983), only the cryptic 5ss was used (lanes 1, 2).
Since the cryptic 5ss is already a suboptimal 5ss (Roca et al. 2003),
we conclude that both the +3A and +3G 5ss are weak. When the
+3A and +3G 5ss were competing against each other, splicing
occurred only via the +3A 5ss (lanes 4, 5). This finding indicates
that the +3A 5ss is much stronger than its +3G counterpart.
Second, we found that correcting positions +4 and/or +5 to
match the consensus can alleviate the effects of the +3 A-to-G
mutation, which is in concordance with our above-mentioned
prediction derived from the pairwise associations. To test for the
rescue of splicing by correcting these positions, we compared two
ACADSB 5ss with the same combination of nucleotides at posi-
tions +4, +5, and +6, but one having A at +3 and the other one G
at +3 (Fig. 7). In general, we found that +3G 5ss use was posi-
tively correlated with the number of consensus nucleotides at
positions +4 to +6 (lanes 1–3, 5). However, the two reciprocal
Figure 3. Scatter plots showing combinations of PWM scores (X-axis) and association-score differences (Y-axis) for 5ss from four data sets. The four
data sets are disease-causing mutations (A, 595 cases), orthologous mouse–human pairs of 5ss (B, 19,940 pairs), SNPs at 5ss (C, 1260 SNPs), and
simulated SNPs at 5ss (D, 8074 cases). Each spot in the data set corresponds to a 5ss and a single-nucleotide change to the 5ss. In each data set, along
the X-axis, we plotted the original 5ss PWM score; in the case of SNPs and orthologous 5ss, the 5ss with the higher score is considered the original
5ss. Along the Y-axis, we plotted the difference in association scores due to the change (score of original pair  score of new pair). A change to a pair
with reduced association score will give a positive score difference, and an increase in association score will give a negative value. The solid lines show
the averages along the X- and Y-axes, whereas the dashed lines show the confidence intervals for the means (calculated by a bootstrap method). The
numbers are also given as text within the plots, with the confidence interval shown in parentheses. The disease panel is clearly biased toward low PWM
scores and greater disruption of associations, compared with the other data sets. The averages for the four data sets are well separated on the basis of
the confidence intervals.
Determinants of 5ss efficiency
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experiments shown in this figure do not match, in the sense that
the activation of the +3G 5ss is influenced by the relative posi-
tion of the two competing 5ss (lanes 1–6, cf. the +3G-spliced
band between both panels). This difference is probably due to the
influence of the sequences that flank the 5ss at positions 16
and +1. Notwithstanding these positional effects, our conclusion
that correction of positions +4 and/or +5 rescues splicing of the
+3G 5ss is still supported by the data.
Finally, the +3G 5ss can be activated by correcting position
+4 alone (Fig. 7, lane 3). This is not surprising, because a base pair
at +4 with U1 might stabilize the wobble G- base pair at +3.
Strikingly, correcting position +5 alone alleviated the severity of
the A-to-G mutation at +3 (Fig. 7, lane 5). This indicates that
nonadjacent interactions (such as those involving positions +3
and +5) at the 5ss can affect splice-site efficiency.
Orthologous 5ss between the mouse and human genomes
We expected that orthologous pairs of 5ss between mouse and
human genomes, which are very similar to each other according
to the PWMs and the association matrices, should show patterns
of nucleotide substitutions that do not substantially disrupt the
PWM score or the association score. We used a published data set
of 54,761 pairs of orthologous 5ss from the human and mouse
genomes (Carmel et al. 2004) to study the nature of differences
between members of these pairs.
We found that 36.5% of these pairs have identical splice-site
sequences and 36.4% show a single nucleotide change. The
nucleotide change between orthologous pairs that differ at a
single position does not usually disrupt the PWM score and the
pairwise associations within 5ss (Fig. 3). We also observed a com-
pensatory trend: If one member of an orthologous 5ss pair has a
weaker PWM score, then its pairwise-association score tends to be
higher (Fig. 8).
In the orthologous 5ss pairs with two nucleotide changes
(19.2%), certain coordinated changes are preferred over others.
For example, +5C+6C changes to +5T+6G more often than ex-
pected (72 vs. 28 expected; both combi-
nations are strongly enriched), whereas
1T+6T to 1C+6A is strongly sup-
pressed (occurs once vs. 20 expected; the
first combination is enhanced, whereas
the second combination is strongly de-
pleted). The probability of a single
change occurring, e.g., +5C to +5T, is
calculated by counting the number of
such transitions over the pairs of which
at least one of them has a C at +5. The
expected number of coordinated pair-
wise changes is calculated by assuming
independence between the transitions at
the two positions in the 5ss. Evidently,
the pairwise-association patterns reflect
constraints on the evolution of 5ss due
to the conserved splicing machinery,
and these association patterns could
hold clues into mechanistic features of
the splicing machinery.
SNPs at 5ss
We expect SNPs that occur at splice sites
to be neutral, i.e., not to affect splice-site
efficiency in a majority of the cases. There have been a few re-
ports of SNPs that do affect splicing (Shinmura et al. 2004; Field
et al. 2005; Skarratt et al. 2005; ElSharawy et al. 2006; Kawase et
al. 2007) but no comprehensive analysis of this phenomenon. In
our study, we used the 1260 SNPs at 5ss (dbSNP) (Smigielski et al.
2000) that are confirmed by population data and lie outside of
positions +1 and +2.
We calculated the PWM scores and pairwise-association
score differences for SNPs (Fig. 3C). The average PWM score for
5ss with SNPs (5.92) is higher than that for simulated SNPs
(5.54), which in turn is higher than the average score for disease-
causing mutations (5.31). The PWM scores of orthologs that
show one difference between human and mouse are higher on
average than the SNP set (6.2 vs. 5.92), suggesting that strong 5ss
(PWM score >6.2) can tolerate such changes without affecting
splicing.
Figure 4. Percentage of nonconsensus nucleotides at positions (X-axis) of the 5ss for five classes of
5ss: all 5ss in human (186,630 cases), 5ss with A at +3 (110,598), 5ss with G at +3 (64,837), 5ss
with SNPs having alleles A/G at position +3 (93), and 5ss with disease-causing A-to-G mutations at +3
(50 cases). 5ss with disease-associated A-to-G mutations at position +3 tend to have nonconsensus
nucleotides at positions +4 and +5 more frequently than the other sets, which suggests their disruptive
nature, based on the association matrix (Fig. 2).
Figure 5. Experimental system used to test 5ss efficiency by a com-
petition assay (Roca et al. 2005). The human beta-globin pre-mRNA has
two 5ss at positions 16 and +1, of which the +1 5ss is always used
because the 16 cryptic 5ss is much weaker (Roca et al. 2003). Replace-
ment of the 16 5ss by the +1 5ss sequence results in both 5ss being
used equally. This system can be used to test the relative efficiencies of
5ss by a competition assay, wherein the 16 and/or +1 5ss are replaced
by the various 5ss to be tested. When different 5ss are compared, their
relative positions are also swapped as the contexts are not equivalent, in
that for 5ss of comparable efficiency, either the +1 or the 16 site can
get more efficiently used. Use of the two competing 5ss results in prod-
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From Figure 3, we can see that the disruption of the asso-
ciations by the SNPs is smaller than the disruption by the simu-
lated SNPs, which in turn is smaller than the disruption by the
5ss disease-causing mutations, suggesting selective pressure on
SNPs to preserve the associations. For instance, Figure 4 shows
that SNPs with alleles A and G at position +3 tend to have con-
sensus nucleotides at positions +4 and +5, as expected from the
previous discussion on +3 A-to-G disease mutations.
By using these findings (see Fig. 3), we were able to establish
criteria to identify SNPs that might disrupt splicing. We used the
average score of the disease set to identify low PWM scores
(5.31). The separation between disease-causing mutations and
the SNPs and orthologous sets was used to identify high PWM-
score differences (1). The average association-score difference
for the disease data set was used to identify high association-score
differences (1.1). We expect disruptive 5ss SNPs to occur at 5ss
with low PWM scores, and for the SNPs to substantially disrupt
either the PWM score or the association scores or both simulta-
neously.
Disruptive 5ss SNP predictions and evidence for their effect
on splicing
By using the criteria listed above, we created five sets from the
1260 SNPs in dbSNP that occur at 5ss (Smigielski et al. 2000). The
sets were picked to dissect the effects of the PWM scores, PWM-
score differences between SNP alleles, and association-score dif-
ferences between SNP alleles. The first set, designated LHH, con-
sists of 35 SNPs at 5ss that have low (L) PWM scores and alleles
with high (H) association-score differences and high (H) PWM-
score differences. The second set, LHL, consists of 35 SNPs at 5ss
with low PWM scores and alleles with high PWM-score differ-
ences and low association-score differences. The third set, LLH,
consists of 43 SNPs at 5ss with low PWM scores and alleles with
low PWM-score differences and high-association score differ-
ences. The fourth set, HLL, consists of 58 SNPs at 5ss with high
PWM scores and alleles with low PWM-score differences and low
association-score differences. Finally, the fifth set, LLL, consists
of 111 SNPs at 5ss with low PWM scores and alleles with low
PWM-score differences and low association-score differences.
The LHH, LLH, and LHL sets of SNPs are expected to be more
disruptive of splicing, whereas the HLL and LLL sets are controls
that should be less disruptive of splicing.
We used EST and mRNA alignments to the genome to es-
tablish disruption caused by SNPs at 5ss, using the UCSC
browser (Kent et al. 2002). The alignments were studied to pick
unambiguous cases of intron retention (at least one intron be-
sides the retained one was spanned by the EST/mRNA), exon
skipping (the skipped exon is otherwise constitutively spliced),
and cryptic splice-site utilization. A prediction was considered
validated if alternative splicing was observed at the 5ss in ques-
tion, and when possible, the EST and mRNA data supporting the
alternative event corresponded to the nonconsensus allele of the
SNP. In the case of exon skipping, it is not possible to ascertain
the allele at the SNP position, but by considering the proportion
of internal exons among RefSeq mRNAs that are skipped in this
manner (3734/166,622), we were able to infer the likely error rate
in making the determination of exon skipping as being due to
the SNP (one in 45). We estimate similar error rates for intron
retention (one in 160) and cryptic-splice-site utilization (one in
70) based on previous work on the relative prevalence of the
different types of alternatively spliced exons (Kim et al. 2007).
Furthermore, we checked that a 5ss following cassette exons
(from the Alt Events track of the UCSC browser) was no more
likely to contain a SNP than a randomly selected 5ss.
In agreement with our expectations, we found that the sets
LHH (10 disruptive SNPs out of 35), LHL (eight disruptive SNPs
out of 35), and LLH (12 disruptive SNPs out of 43) are more
disruptive than the control sets HLL (five disruptive SNPs out of
Figure 7. The deleterious effect of the +3 A-to-G mutation can be
alleviated by correcting positions +4 and/or +5. In this competition assay,
we created two sequences from the ACADSB exon 3 5ss: one with +3A
and another with +3G (for the experimental strategy, see Fig. 5; for the
ACADSB 5ss sequences, see Fig. 6). The same mutations were simulta-
neously introduced at positions +4, +5, and +6 at both 5ss, to test their
compensatory effects vis-à-vis the +3 A-to-G mutations. The nucleotides
at positions +4, +5, and +6 are listed above the lanes, and the consensus
nucleotides are boxed. The left and right panels are the same, except that
the positions of the +3A and +3G 5ss are swapped (indicated on the top
diagram). With a few exceptions, the general trend is that the +3G 5ss
was used to a greater extent as the number of consensus nucleotides at
positions +4 to +6 was increased (lanes 1–3, 5). The degree of use of the
+3G 5ss was not the same for identical mutants in the two panels (for
details, see text), but despite these positional effects, the trend remains.
The +3G 5ss can be activated by correcting position +4 alone (lane 3) or
+5 alone (lane 5). The rescue by +5 alone is surprising and indicates that
associations between nonadjacent positions can affect splice-site effi-
ciency.
Figure 6. The +3 A-to G-mutation in the ACADSB 5ss has a severe
effect on splicing efficiency. By using the competition strategy described
in Figure 5, we performed three experiments. First, the ACADSB wild-type
5ss (+3A, GGG/GUACAU) and the mutant (+3G, GGG/GUGCAU), which
differs by having a G at +3, were placed in competition against the
beta-globin cryptic (GUG/GUGAGG) 5ss at 16 (Treisman et al. 1983).
The cryptic 5ss at 16 was the only 5ss used (lanes 1,2), indicating that
both +3A and +3G 5ss are very weak. Second, a competition was done
between +3A and +3G, which resulted in splicing only via the +3A 5ss
(lanes 4,5). Third, the same 5ss was placed on the same substrate at both
locations. Whereas the substrate with two +3A 5ss resulted in use of both
16 and +1 5ss (lane 3), two +3G 5ss did not show any splicing (lane
6). Together, these results indicate that the +3A 5ss is much stronger
than the +3G 5ss.
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58) and LLL (19 disruptive SNPs out 111). By using bootstrapping
to estimate the variance of these numbers, we found that the LLL
and LLH sets are significantly different from each other (P-value
of 0.0003 using an unpaired t-test). The stronger disruption
shown by the LLH set compared with the LLL set confirms the
predictive nature of the association scores. A sampling of SNPs
from these sets is given in Table 2.
This analysis is confounded by the fact that the ESTs might
not have sampled the SNP alleles of interest, due to the genotype
of the source. The intronic SNPs are also not likely to be sampled
in the ESTs. In addition, some of the alternative spliced products
might be degraded by NMD, due to the presence of a premature
stop codon and thus would not be observed (Lejeune and Maquat
2005). In light of these limitations, it is encouraging that we still
find such a high confirmation rate.
We expected the genotypes to show a preference for alleles
of SNPs at 5ss that do not disrupt splicing, but we did not detect
a strong signal in the distribution of genotypes. The effect of
SNPs at 5ss might be alleviated by the sequence context. For
example, in the ACADM (also called MCAD) gene (Nielsen et al.
2007), one allele of a SNP creates an ESS, and a mutation that
disrupts a nearby ESE causes exon skipping only in individuals
with the ESS-creating allele. Even if splicing is affected, there
might be no phenotypic effects due to the following: (1) a small
reduction in the correct mRNA levels; (2) compensation in the
genetic network; (3) the function of the disrupted gene is re-
quired only under certain conditions; or (4) the alternate product
due to the disruption of the particular 5ss is also functional.
Nevertheless, such SNPs can offer a window into the investiga-
tion of the genetic network. This analysis will allow investigation
of disruptive SNPs and their role in complex diseases.
Discussion
We have shown that the effects of disease-causing mutations are
often a result of the disruption of conserved patterns in associa-
tions between nucleotides at different
positions within the 5ss, and SNPs that
disrupt these pairwise associations tend
to affect splicing. A majority of SNPs re-
spect the associations, as expected from
SNP neutrality. In addition, we have
shown that orthologous 5ss mouse–
human pairs show changes that likewise
respect the associations, which suggests
the existence of selective pressure to
maintain them. A set of simulated SNPs
is more disruptive of associations than
neutral SNPs but is better than the dis-
ease-causing mutations in this respect.
This is expected from the lack of selec-
tion pressure on the simulated SNPs.
The conservation of the associa-
tions is indicative of selective pressures
reflecting functional features of the
splicing machinery, and allows infer-
ences to be made about the underlying
mechanisms. The pairwise associations
confirm many known effects, but also
suggest new areas for exploration. We
found pairwise associations probably re-
lated to U1 base pairing, such as specific
patterns involving consensus and nonconsensus nucleotides
across the exon–intron boundary. We found one association
probably related to base pairing to U6, but none related to U5.
The long-range associations are likely related to protein–RNA in-
teractions, and further experiments should shed light on them.
Similar studies could be carried out using 3ss. However, the
longer span of this motif (Sheth et al. 2006) and its more plastic
organization suggest that the pairwise associations at 3ss will not
reveal as many biases as the associations at 5ss.
By using the data from disease-causing mutations in 5ss,
differences between orthologous pairs of mouse and human 5ss,
and genomic data for five species, we were able to generate cri-
teria for prediction of splicing-disruptive SNPs at 5ss. We have
shown that circumstantial evidence from ESTs provides support
for these predictions and encourages further experiments to
study their effects in vivo.
The disruptive SNPs may provide insights into genetic net-
works. If a proven disruptive SNP is in Hardy-Weinberg equilib-
rium, it suggests that the genetic network is immune to the
change, and this can be a starting point for investigating the
reasons for this robustness of the network. Alternatively, such
SNPs might be implicated in complex diseases, wherein their
effects are apparent only under certain genetic and environmen-
tal conditions. For example, there has been work on SNPs affect-
ing the p53 pathway, such as a SNP in the MDM2 gene that alters
a transcription-factor binding site and hence the levels of p53
(Bond and Levine 2007). This results in phenotypes ranging from
an effect on fertility, to the onset of tumor formation, and the
response to various therapies, such as estrogen replacement. Our
study is a first step in investigating the effect of SNPs at 5ss on a
genomic scale. The consequences of the disruptions could be
stochastic in nature, leading to effects that might not be readily
discernible in in vitro systems but might nevertheless affect the
in vivo phenotypes.
This study illustrates the power of the convergence of dif-
ferent data sets for obtaining insights into mechanisms of gene
Figure 8. Association improvements can compensate for reductions in PWM scores. In orthologous
mouse–human pairs of 5ss, association scores improve as PWM scores get weaker. The graph shows
the average of the PWM-score differences (white bars) as well as association-score differences (black
bars) for the orthologous 5ss mouse–human pairs, organized by the number of nucleotide differences
between the members of each pair (X-axis). A positive difference means a decrease in the score (and
vice versa). The differences in PWM scores are always positive, as the 5ss with the higher score within
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expression and for understanding the neutral and disease-
causing nucleotide changes found in human populations.
Methods
Scoring splice sites with PWM
PWMs reflect the frequencies of the 4 nt (A, C, G, and T) at each
position of the splice site. PWMs can be used to score a site by
converting the frequencies into a log-odds score (log of the ratio
of the actual frequency and the expected frequency) (Sheth et al.
2006).
Scoring associations within splice sites
For the associations, we calculated the expected frequencies for
each combination of a pair of positions and nucleotides, using
the PWM and assuming independence of positions from each
other. We then calculated a log-odds score for the combination,
based on the actual numbers observed in the genomic data set.
The total association score for a given 5ss is the sum of the
log-odds score for each nucleotide pair at the 5ss. The change in
association score measures the disruption (or enhancement) of
the pairwise associations due to changes at the 5ss caused by
SNPs, mutations, or differences between pairs of orthologous
5ss.
In order to avoid small statistical fluctuations affecting the
scores (e.g., an actual occurrence of three versus an expected
number of 45 would give the relevant pair a strong negative
score), we excluded those pairs that are expected less than 50
times in the genome. This does not affect the scoring of most
splice sites, as these pairs are by definition rare.
Collection of data sets
From the HGMD database (Stenson et al. 2003), we collected
1772 disease-causing mutations affecting U2-type GT-AG 5ss se-
quences. After excluding mutations affecting +1 and +2 of the
5ss, we were left with 582 mutations affecting the positions 3
to 1 and +3 to +6, which we used in our analysis. An additional
13 5ss mutations changing a +3 A to G at 5ss were added from
a separate source (Madsen et al. 2006). We randomly selected 5ss
from SpliceRack (Sheth et al. 2006) and mutated a randomly
selected position in the 5ss to generate a list of simulated SNPs in
5ss. From dbSNP (Smigielski et al. 2000), we extracted SNPs that
have population data and mapped them to the genome to iden-
tify SNPs at 5ss. For the orthologous set, we used a published
data set (Carmel et al. 2004).
In vitro splicing
In the 5ss competition assay, each test ACADSB 5ss replaces the
beta-globin 5ss at positions 16 and/or +1 (Fig. 5). The compe-
tition between the two 5ss provides an estimate of the difference
in their intrinsic strengths.
The beta-globin wild-type 5ss and the cryptic 5ss at posi-
tion 16 were replaced by various mutant ACADSB 5ss by PCR
mutagenesis. We inactivated a second cryptic 5ss in beta-globin
that is located 38 nt upstream of the authentic 5ss (Treisman et
al. 1983) to prevent competition with the various ACADSB 5ss.
The different mutant beta-globin minigenes, inserted into the
pSP64 vector (Promega) were in vitro transcribed (Mayeda and
Krainer 1999b). The pre-mRNA transcripts were then spliced in
vitro using HeLa cell nuclear extract (Mayeda and Krainer 1999a),
and the products were analyzed by electrophoresis in 5.5% poly-
acrylamide/7M urea gels.
Table 2. A selection of SNPs at 5ss
Gene 5ss SNP Freq. PS PD AD Effect Allele
PPIL2 (C/T)AGGTTGGC rs12484060 0.49 3.01 1.10 2.66 ES/IR C/T (IR)
UTP15 (T/C)AGGTTGGC rs16870610 0.14 3.01 1.10 2.66 No
PLD2 C(G/A)GGTAGAG rs3764897 0.32 4.08 1.66 3.17 CS
MGC88374 A(A/T)GGTTGTG rs3737161 0.75 0.84 1.50 2.81 ES
DENND1B C(G/A)AGTAATA rs17641524 0.22 3.47 1.66 1.98 ES
PYCR1 A(A/G)GGTGAAG rs34575645 0.01 5.23 1.66 1.14 IR A
LOC400988 ATCGTG(C/A)GT rs11894651 0.71 3.51 2.18 3.05 ES
COL11A1 CCTGTA(T/A)GT rs12136577 0.12 4.72 1.85 1.52 ES
C6orf191 TGAGTA(A/C)GT rs17396809 0.15 4.02 2.18 2.93 No
COL25A1 GGGGTCC(G/A)T rs1859143 0.54 1.38 2.18 1.30 CS/IR G (IR)
COASY TATGTAAG(C/T) rs34135057 0.02 5.34 1.13 1.60 IR C
SYNE1 AAAGTTAG(T/C) rs9397102 0.51 3.70 1.13 1.45 CS C/T
NKAIN4 (A/C)AGGTGAGT rs1129659 0.65 8.37 0.10 0.15 No
ZNF423 (C/A)GGGTAAGT rs16947734 0.02 7.21 0.10 0.99 No
COL17A1 C(G/C)GGTAAGT rs17116450 0.13 7.21 0.06 0.14 No
USP14 AA(T/C)GTAAGT rs563155 0.49 6.34 0.84 0.22 No
TGFBR3 CA(C/T)GTAAGT rs35352606 0.03 6.44 0.84 0.02 No
TRIO CAGGT(A/G)AGT rs16903358 0.03 8.87 0.50 0.60 No
NUP88 CAGGT(C/T)AGT rs739768 0.69 5.89 0.01 0.58 No
PAQR3 CAGGTA(G/T)GT rs13108247 0.33 7.13 0.11 0.14 IR T
PCDH11X CAGGTA(T/G)GG rs4252206 0.50 6.26 0.11 0.01 No
CCDC60 CTGGTAA(A/T)T rs2014138 0.20 5.19 0.15 0.12 No
AZI2 AAGGTAAT(T/A) rs3762797 0.32 6.44 0.98 1.25 IR A/T
PDE4D CAGGTAAG(G/A) rs1553114 0.21 8.00 0.11 0.23 No
Out of 113 SNP candidates predicted to affect splicing, 30 show EST evidence of an effect on splicing, whereas only 24 out of 169 control SNPs (likely
neutral SNPs according to our study) did. For details of the EST analysis, see the Methods section. The table shows 12 selected cases for each set: the
candidate (upper half) and control (lower half) SNPs. We found three types of alternative splicing patterns: exon skipping (ES), intron retention (IR), or
selection of a nearby cryptic 5ss (CS). The allele disrupting the 5ss, if identifiable, is indicated in the last column. The “Freq.” column gives the
maximum frequency of the minor allele. In some cases the frequency is >0.5 because the minor allele becomes a major allele in some populations. The
PWM score for the stronger allele (PS), the PWM-score difference (PD), and the association-score difference (AD) between alleles are also indicated.
Determinants of 5ss efficiency
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EST analysis
By using the UCSC genome browser (Kent et al. 2002), we located
the relevant SNPs by entering the rs id numbers provided by
dbSNP into the “position/search” input area. We used visual in-
spection to determine the nature of the alternative splicing event
and tried to identify the allele that might be responsible for this
splicing alteration. The browser was configured to display the
“human mRNAs” and “spliced ESTs” tracks in “full” mode. De-
termining which allele was used in each EST was simplified by
setting the “color track by codons or bases” option to “different
mRNA bases” (follow the link on the track name to turn on this
feature).
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